1. What Is the Digital Therapeutics Diabetes Market?
The Digital Therapeutics Diabetes Market covers software-based therapeutic interventions delivering behavioural, cognitive, and lifestyle management to individuals with type 1, type 2, and pre-diabetes for glycaemic control and prevention. Digital therapeutics diabetes encompasses FDA-cleared glucose management apps, diabetes prevention programme digital delivery, and CGM-integrated coaching platforms. Market dynamics reflect FDA DTx regulatory pathway enabling prescription reimbursement, digital DPP achieving CDC recognition and insurer coverage, and CGM-integrated behaviour coaching demonstrating superior A1c reduction.
2. Digital Therapeutics Diabetes Market Size & Forecast
3. Emerging Technologies
- CGM data-integrated AI diabetes coaching providing real-time dietary guidance from glucose response patterns are advancing as personalised management tools. Growing adoption is driven by CGM-connected behaviour change improvement requirements.
- Closed-loop insulin delivery integration with digital therapeutic coaching creating comprehensive type 1 diabetes management are advancing. Growing adoption is driven by T1D glycaemic control optimisation requirements.
- Digital diabetes prevention programme personalisation using AI to adapt content to individual behaviour change barriers are advancing. Growing adoption is driven by DPP completion rate improvement requirements.
- Social support digital communities connecting diabetes patients with peers for shared motivation are advancing as engagement tools. Growing adoption is driven by long-term digital therapeutic engagement maintenance requirements.
Similar technologies are also transforming adjacent markets. Learn more in our IoT In Remote Patient Monitoring Market.
4. Key Market Opportunity
Demand is strongest in the Digital Therapeutics Diabetes Market at the employer digital diabetes prevention programme sub-market, where CDC-recognised DPP creates employer benefits revenue as Omada and Noom serve pre-diabetes employees. CGM-integrated diabetes coaching creates a premium clinical opportunity as Livongo and Teladoc demonstrate A1c reduction in commercial insurance populations. Type 2 diabetes prescription DTx creates an emerging opportunity as FDA-cleared glucose management apps achieve payer reimbursement. Asia Pacific diabetes digital therapeutics creates geographic expansion as Chinese, Japanese, and Indian diabetes epidemic drives digital management platform adoption.
5. Top Companies in the Digital Therapeutics Diabetes Market
The following organisations hold leading positions in the Digital Therapeutics Diabetes Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Omada Health (DPP)
- Teladoc Livongo (CGM coaching)
- Noom Med (DTx)
- Virta Health (T2D reversal)
- One Drop
- Glooko
- Dario Health
- mySugr (Roche)
- Cecelia Health
- Welldoc (BlueStar)
6. Market Segmentation
The Digital Therapeutics Diabetes Market is analysed across 3 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Type | Type 2 Diabetes Management Prediabetes Prevention Type 1 CGM Integration Gestational Diabetes |
| By Delivery | Prescription DTx OTC App Employer DPP Benefit Payer DPP |
| By Geography | North America The U.S. Canada Europe The UK Germany France Italy Spain Denmark Netherlands Finland Sweden Norway Russia Austria Poland Rest of Europe Asia Pacific China Japan India South Korea Australia Indonesia Vietnam Philippines Singapore Taiwan Thailand Rest of Asia Pacific Latin America Brazil Mexico Argentina Rest of South America Middle East and Africa GCC Countries Israel South Africa Rest of Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Digital Therapeutics Diabetes Market trajectory over the forecast period:
Omada Health Digital DPP Achieves 500,000 Enrolled Pre-Diabetes Participants Across Employer Plans.Omada Health CDC-recognised digital diabetes prevention programme achieving 500,000 enrolled pre-diabetes participants across employer and payer contracts in 2024 demonstrates digital DPP at commercial scale. Omada DPP achieving 4.7 percent average weight loss at 12 months demonstrates clinical efficacy of digital diabetes prevention at scale.
Livongo and Teladoc Whole Person Health Achieve 700,000 Active Chronic Condition Management Members.Teladoc Livongo chronic condition management achieving 700,000 active diabetes and hypertension members in 2024 demonstrates CGM-integrated digital diabetes management at commercial scale. Livongo personalised coaching achieving 0.8 percent A1c reduction in type 2 diabetes members demonstrates digital therapeutic glycaemic benefit.
Noom Med Digital Weight and Diabetes Management Achieves FDA Breakthrough Device Designation for Obesity Digital Treatment.Noom Med prescription digital therapeutic for obesity management achieving FDA Breakthrough Device Designation in 2024 demonstrates regulatory recognition of digital behaviour weight loss for diabetes risk reduction. Noom achieving 2 percent A1c reduction in overweight type 2 diabetes patients through digital behavioural weight loss intervention demonstrates glycaemic benefit.
For related market intelligence, see the AI Powered Clinical Decision Support Market.
8. Segmental Analysis
By type, the Type 2 Diabetes and Prediabetes Prevention segment dominated the Digital Therapeutics Diabetes Market in 2025. Representing the largest revenue category as employer DPP and CGM coaching drive the majority of digital diabetes programme revenue. The GLP-1 Plus Digital Coaching segment is the fastest-growing category, advancing as GLP-1 medication adherence and behaviour change coaching integrates with weight loss drug programmes.
By delivery, the Employer DPP Benefit segment dominated the Digital Therapeutics Diabetes Market in 2025. Representing the largest delivery revenue share. The Payer Prescription DTx segment is the fastest-growing delivery category, advancing as clinical protocol standardisation and reimbursement expansion broaden market access. Revenue diversification across delivery reflects the range of buyer segments and procurement approaches within the Digital Therapeutics Diabetes Market.
9. Regional Analysis
Regional demand patterns across the Digital Therapeutics Diabetes Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America accounted for the largest share of the Digital Therapeutics Diabetes Market in 2025, holding 50.3% of the global market. Pharmaceutical companies, endocrinologists, and diabetes care technology organisations are deploying digital therapeutics platforms for medication adherence drives, glycaemic monitoring guidance, and lifestyle behaviour change in type 2 diabetes management. FDA Software as a Medical Device approval pathways for prescription digital therapeutics and growing commercial health insurer coverage for diabetes digital therapeutics are encouraging platform development. High diabetes prevalence, large uncontrolled glycaemic patient population, and strong pharmaceutical investment in digital companion programmes are generating regional demand.
Highest CAGR Region
Asia Pacific is expected to register the highest CAGR of 28.36% during the forecast period. Pharmaceutical companies, healthcare providers, and digital health organisations across China, India, Japan, and Southeast Asia are deploying diabetes digital therapeutic platforms to manage the world's largest and fastest-growing diabetes patient populations. Growing diabetes epidemic severity, expanding smartphone adoption enabling mobile health application delivery, and increasing government diabetes prevention and management investment are generating demand. Government national diabetes management strategies and rising healthcare system pressure from diabetes complications burden are accelerating adoption.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology Adoption Trends and Innovation Tracking
- • Custom Company Profiling and Benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country-Level Opportunity Mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Digital Therapeutics Diabetes Market was valued at USD 3.17 Bn in 2025 and is projected to reach USD 18.83 Bn by 2034, growing at a CAGR of 21.9% over the 2026–2034 forecast period.
The Digital Therapeutics Diabetes Market is projected to grow at a CAGR of 21.9% from 2026 to 2034.
North America accounted for the largest share of the Digital Therapeutics Diabetes Market in 2025, holding 50.3% of the global market.
The leading companies in the Digital Therapeutics Diabetes Market include Omada Health (DPP), Teladoc Livongo (CGM coaching), Noom Med (DTx), Virta Health (T2D reversal), One Drop, Glooko, Dario Health, mySugr (Roche), Cecelia Health, Welldoc (BlueStar).
Omada health digital dpp achieves 500,000 enrolled pre-diabetes participants across employer plans.
By type, the Type 2 Diabetes and Prediabetes Prevention segment dominated the Digital Therapeutics Diabetes Market in 2025.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.